CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Kumar Rashmi Director | Sale 10b5-1 | −15,000 | $4.46 | $67K | 171,889 |
| 2024-10-11 | DIAZ PAUL J President and CEO | Sale 10b5-1 | −15,000 | $22.93 | $344K | 962,378 |
| 2024-09-11 | Muzzey Dale Chief Scientific Officer | Sale | −2,100 | $26.17 | $55K | 108,013 |
| 2024-09-11 | DIAZ PAUL J President and CEO | Sale 10b5-1 | −15,000 | $26.72 | $401K | 977,378 |
| 2024-09-09 | Dreismann Heinrich Director | Sale | −10,000 | $27.05 | $271K | 121,648 |
| 2024-09-03 | Reitan Colleen F Director | Sale 10b5-1 | −46,012 | $27.95 | $1.3M | 42,533 |
| 2024-08-21 | Ancona Margaret SVP, Chief of Staff | Sale | −11,538 | $27.82 | $321K | 79,366 |
| 2024-08-19 | Kumar Rashmi Director | Sale 10b5-1 | −7,500 | $28.01 | $210K | 77,392 |
| 2024-06-04 | SPIEGELMAN DANIEL K Director | Sale 10b5-1 | −3,788 | $22.05 | $84K | 32,917 |
| 2024-06-03 | SPIEGELMAN DANIEL K Director | Sale 10b5-1 | −3,788 | $22.04 | $83K | 36,705 |
| 2024-05-15 | DIAZ PAUL J President and CEO | Sale | −75,000 | $25.07 | $1.9M | 1,066,166 |
| 2024-05-14 | DIAZ PAUL J President and CEO | Sale | −95,000 | $25.21 | $2.4M | 1,141,166 |
| 2024-05-13 | Newcomer Lee Nisley Director | Sale | −6,200 | $25.30 | $157K | 66,650 |
| 2024-05-13 | DIAZ PAUL J President and CEO | Sale | −57,844 | $25.13 | $1.5M | 1,236,166 |
| 2023-12-01 | Riggsbee Richard Bryan Chief Financial Officer | Sale 10b5-1 | −30,000 | $19.09 | $573K | 291,812 |
| 2023-11-01 | Riggsbee Richard Bryan Chief Financial Officer | Sale 10b5-1 | −30,000 | $15.69 | $471K | 321,812 |
| 2023-06-02 | SPIEGELMAN DANIEL K Director | Sale | −8,638 | $23.01 | $199K | 40,493 |
| 2023-03-27 | Lambert Nicole Chief Operating Officer | Sale | −6,433 | $23.48 | $151K | 240,506 |
Page 1 of 1 · 18 trades